The healthcare providers’ intro to CEFALY
Innovative neuromodulation therapy for migraine
CEFALY Clinical Education and Support
CEFALY’s FDA-cleared neuromodulation device is a clinically proven, non-pharmaceutical treatment for migraine relief and prevention. With high efficacy, no serious adverse side effects and no prescription required, CEFALY can be used on its own or alongside other therapies. Interested in learning more? We’re here to answer questions about CEFALY, provide educational materials, and send you a demo kit as part of our CEFALY Certified program.
Get CEFALY
Interested in learning more about CEFALY’s clinically proven neuromodulation therapy? Request a CEFALY Connected demo kit and enroll in our CEFALY Certified provider program.
Please select a form form the dropdown list of 'Choose Gravity Form'.
Breakthrough migraine treatment used by customers worldwide
One of the best
safety/efficacy ratios on the market for acute and preventive relief from migraines
Drug-free pain relief
that helps limit dependency on medication and reduces risk of Medication Overuse Headaches
Resources for healthcare professionals
Download printable info sheets to serve as a quick CEFALY reference
Indications
CEFALY is indicated to be used for:
- Acute treatment of migraine with or without aura in patients 18 years of age or older.
- Preventative treatment of migraine with or without aura in patients 18 years of age or older.
Do not use CEFALY if you:
- Have metallic or electronic devices implanted in the head
- Are suffering from pain of unknown origin or
- Have a cardiac pacemaker or an implanted or wearable defibrillator.
CEFALY is ideal for migraine patients who:
- Prefer non-pharmaceutical migraine treatment options
- Don’t respond to pharmaceutical treatments
- Cannot tolerate pharmaceutical therapies
- Are seeking clinically proven alternatives to pharmaceuticals
- Have prior medical conditions and are unable to take traditional pharmaceuticals
- Have limited access to outpatient treatment procedures
Report an Adverse Event
To report suspected adverse reactions, contact us at…